Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Bauer Mehren, Anna ^a   Bundschus, Markus ^b,c   Rautschka, Michael ^a   Mayer, Miguel A ^a   Sanz, Ferran ^a   Furlong, Laura I ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF MUNICH   (Germany)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PERHEXILINE;

ANGINA PECTORIS; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENVIRONMENTAL DISEASE; ENVIRONMENTAL FACTOR; GENE CLUSTER; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; IMMUNE COMPLEX DISEASE; MOLECULAR GENETICS; RHABDOMYOLYSIS; ENVIRONMENT; GENERAL ASPECTS OF DISEASE; GENETICS; MULTIGENE FAMILY; PHENOTYPE;

CLUSTER ANALYSIS; DISEASE; ENVIRONMENT; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; HUMANS; MULTIGENE FAMILY; PHENOTYPE;

EID: 79958795334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020284     Document Type: Article

References (71)

1. Botstein D, Risch N, (2003) Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33: 228-237.
2. Kann MG, (2010) Advances in translational bioinformatics: computational approaches for the hunting of disease genes. Brief Bioinform 11: 96-110.
3. Scriver CR, Waters PJ, (1999) Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet 15: 267-272.
4. Hirschhorn JN, Daly MJ, (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6: 95-108.
5. Cokol M, Iossifov I, Weinreb C, Rzhetsky A, (2005) Emergent behavior of growing knowledge about molecular interactions. Nat Biotechnol 23: 1243-1247.
6. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA, (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33: D514-517.
7. Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, et al. (2001) Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J 1: 167-170.
8. Mattingly CJ, Rosenstein MC, Davis AP, Colby GT, Forrest JN, et al. (2006) The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks. Toxicol Sci 92: 587-595.
9. Ananiadou S, Pyysalo S, Tsujii Ji, Kell DB, (2010) Event extraction for systems biology by text mining the literature. Trends Biotechnol 28: 381-390.
10. Snead MP, Yates JRW, (1999) Clinical and molecular genetics of Stickler syndrome. J Med Genet 36: 353-359.
11. Ahmad NN, Ala-Kokko L, Knowlton RG, Jimenez SA, Weaver EJ, et al. (1991) Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci 88: 6624-6627.
12. Melkoniemi M, Brunner H, Manouvrier S, Hennekam R, Supertifurga A, et al. (2000) Autosomal Recessive Disorder Otospondylomegaepiphyseal Dysplasia Is Associated with Loss-of-Function Mutations in the COL11A2 Gene. Am J Hum Genet 66: 368-377.
13. Lim J, Hao T, Shaw C, Patel AJ, Szabó G, et al. (2006) A Protein-Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration. Cell 125: 801-814.
14. Jones S, Zhang X, Parsons DW, Lin JC-H, Leary RJ, et al. (2008) Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses. Science 321: 1801-1806.
15. D'Andrea AD, Grompe M, (2003) The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3: 23-34.
16. Reeuwijk Jv, Brunner HG, Bokhoven Hv, (2005) Glyc-O-genetics of Walker-Warburg syndrome. Clin Genet 67: 281-289.
17. Hartwell LH, Hopfield JJ, Leibler S, Murray AW, (1999) From molecular to modular cell biology. Nature 402: C47-52.
18. Oti M, Brunner HG, (2007) The modular nature of genetic diseases. Clin Genet 71: 1-11.
19. Suthram S, Dudley JT, Chiang AP, Chen R, Hastie TJ, et al. (2010) Network-Based Elucidation of Human Disease Similarities Reveals Common Functional Modules Enriched for Pluripotent Drug Targets. PLoS Comp Biol 6.
20. Zaghloul NA, Katsanis N, (2010) Functional modules, mutational load and human genetic disease. Trends Genet 26: 168-176.
21. Barabasi A-L, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56-68.
22. Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proc Natl Acad Sci 104: 8685-8690.
23. Przulj N, Wigle DA, Jurisica I, (2004) Functional topology in a network of protein interactions. Bioinformatics 20: 340-348.
24. Yildirim MA, Goh K-I, Cusick ME, Barabasi A-L, Vidal M, (2007) Drug-target network. Nat Biotechnol 25: 1119-1126.
25. Butts CT, (2009) Revisiting the Foundations of Network Analysis. Science 325: 414-416.
26. Barabási A-L, Oltvai ZN, (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113.
27. Sharan R, Ulitsky I, Shamir R, (2007) Network-based prediction of protein function. Mol Syst Biol 3.
28. Bauer-Mehren A, Rautschka M, Sanz F, Furlong LI, (2010) DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics 26: 2924-2926.
29. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, et al. (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20: 3426-3439.
30. Garraway LA, Sellers WR, (2006) From integrated genomics to tumor lineage dependency. Cancer Res 66: 2506-2508.
31. Dipple KM, McCabe ER, (2000) Modifier genes convert "simple" Mendelian disorders to complex traits. Mol Genet Metab 71: 43-50.
32. Lima-Mendez G, Helden Jv, (2009) The powerful law of the power law and other myths in network biology. Mol Biosyst 5: 1482-1493.
33. López García De Lomana A, Beg QK, De Fabritiis G, Villà-Freixa J, (2010) Statistical analysis of global connectivity and activity distributions in cellular networks. J Comput Biol 17: 869-878.
34. Freudenberg J, Propping P, (2002) A similarity-based method for genome-wide prediction of disease-relevant human genes. Bioinformatics 18: S110-115.
35. van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JAM, (2006) A text-mining analysis of the human phenome. Eur J Hum Genet 14: 535-542.
36. Cerami E, Demir E, Schultz N, Taylor BS, Sander C, (2010) Automated Network Analysis Identifies Core Pathways in Glioblastoma. PLoS ONE 5.
37. Li Y, Agarwal P, (2009) A Pathway-Based View of Human Diseases and Disease Relationships. PLoS ONE 4: e4346.
38. Margadant C, Sonnenberg A, (2010) Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Reports 11: 97-105.
39. Chavali S, Barrenas F, Kanduri K, Benson M, (2010) Network properties of human disease genes with pleiotropic effects. BMC Systems Biology 4: 78.
40. Huberts DHEW, van der Klei IJ, (2010) Moonlighting proteins: an intriguing mode of multitasking. Biochim Biophys Acta 1803: 520-525.
41. Fernández A, Sessel S, (2009) Selective antagonism of anticancer drugs for side-effect removal. Trends Pharmacol Sci 30: 403-410.
42. Berger SI, Iyengar R, (2009) Network analyses in systems pharmacology. Bioinformatics 25: 2466-2472.
43. Bauer-Mehren A, Furlong LI, Sanz F, (2009) Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 5: 290.
44. De Luca L, Mebazaa A, Filippatos G, Parissis JT, Böhm M, et al. (2008) Overview of emerging pharmacologic agents for acute heart failure syndromes. Eur J Heart Fail 10: 201-213.
45. Kennedy JA, Kiosoglous AJ, Murphy GA, Pelle MA, Horowitz JD, (2000) Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. J Cardiovasc Pharmacol 36: 794-801.
46. Celik I, Gallicchio L, Boyd K, Lam TK, Matanoski G, et al. (2008) Arsenic in drinking water and lung cancer: a systematic review. Environ Res 108: 48-55.
47. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, et al. (1995) Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55: 1296-1300.
48. Radosavljević V, Jakovljević B, (2008) Arsenic and bladder cancer: observations and suggestions. J Environ Health 71: 40-42.
49. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, et al. (1992) Cancer risks from arsenic in drinking water. Environ Health Perspect 97: 259-267.
50. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, et al. (1995) Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 141: 198-209.
51. Yang C-Y, Chang C-C, Chiu H-F, (2008) Does arsenic exposure increase the risk for prostate cancer? J Toxicol Environ Health A 71: 1559-1563.
52. Park S, Bae J, Nam B-H, Yoo K-Y, (2008) Aetiology of cancer in Asia. Asian Pac J Cancer Prev 9: 371-380.
53. Sankaranarayanan R, Boffetta P, (2010) Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol.
54. Thun MJ, DeLancey JO, Center MM, Jemal A, Elizabeth MW, (2010) The global burden of cancer: priorities for prevention. Carcinogenesis 31: 100-110.
55. Navarro Silvera SA, Rohan TE, (2007) Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 18: 7-27.
56. Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, et al. (2006) Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers Prev 15: 1367-1375.
57. Bau D-T, Wang T-S, Chung C-H, Wang ASS, Jan K-Y, (2002) Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. Environ Health Perspect 110 (Suppl 5): 753-756.
58. Duerr RH, (2003) Update on the genetics of inflammatory bowel disease. J Clin Gastroenterol 37: 358-367.
59. Scaldaferri F, Fiocchi C, (2007) Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 8: 171-178.
60. The UniProt C, (2010) The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 38: D142-148.
61. Altman RB, (2007) PharmGKB: a logical home for knowledge relating genotype to drug response phenotype. Nat Genet 39: 426.
62. Bundschus M, Dejori M, Stetter M, Tresp V, Kriegel H-P, (2008) Extraction of semantic biomedical relations from text using conditional random fields. BMC Bioinformatics 9: 207.
63. Bauer-Mehren A, Furlong L, Rautschka M, Sanz F, (2009) From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways. BMC Bioinformatics 10: S6-S6.
64. Mitchell JA, Aronson AR, Mork JG, Folk LC, Humphrey SM, et al. (2003) Gene Indexing: Characterization and Analysis of NLM's GeneRIFs. AMIA Annu Symp Pro 2003: 460-464.
65. Lu Z, Cohen KB, Hunter L, (2007) GeneRIF QUALITY ASSURANCE AS SUMMARY REVISION. Pac Symp Biocomput pp. 269-280.
66. Rubinstein R, Simon I, (2005) MILANO- custom annotation of microarray results using automatic literature searches. BMC Bioinformatics 6: 12.
67. Newman MEJ, (2003) The structure and function of complex networks. SIAM Review 45: 167-256.
68. Gabor C, Tamas N, (2006) The igraph Software Package for Complex Network Research. InterJournal Complex Systems.
69. van Dongen S, (2000) Graph Clustering by Flow Simulation. Centers for Mathematics and Computer Science, University of Utrecht.
70. Enright AJ, Van Dongen S, Ouzounis CA, (2002) An efficient algorithm for large-scale detection of protein families. Nucl Acids Res 30: 1575-1584.
71. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabási AL, (2002) Hierarchical organization of modularity in metabolic networks. Science (New York, NY) 297: 1551-1555.